Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8
Martin Filipits, Margaretha Rudas, Verena Kainz, et al.
The Lancet. Oncology
|
August 8, 2020
Knowledge gaps in oncoplastic breast surgery
Walter P Weber, Monica Morrow, Jana de Boniface, et al.
The Lancet. Oncology
|
February 24, 2019
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant, Georg Pfeiler, Günther G Steger, et al.
Journal of Translational Medicine
|
October 8, 2024
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine
Viktoria Knöbl, Lukas Maier, Stefan Grasl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
Christian F Singer, Yen Y Tan, Florian Fitzal, et al.
Virchows Archiv : an International Journal of Pathology
|
May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
Kristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
The Lancet. Oncology
|
August 23, 2008
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Michael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, et al.
The New England Journal of Medicine
|
February 14, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer
Michael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group
Peter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
Breast Care (Basel, Switzerland)
|
June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8
Martin Filipits, Margaretha Rudas, Verena Kainz, et al.
The Lancet. Oncology
|
August 8, 2020
Knowledge gaps in oncoplastic breast surgery
Walter P Weber, Monica Morrow, Jana de Boniface, et al.
The Lancet. Oncology
|
February 24, 2019
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant, Georg Pfeiler, Günther G Steger, et al.
Journal of Translational Medicine
|
October 8, 2024
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine
Viktoria Knöbl, Lukas Maier, Stefan Grasl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
Christian F Singer, Yen Y Tan, Florian Fitzal, et al.
Virchows Archiv : an International Journal of Pathology
|
May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
Kristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
The Lancet. Oncology
|
August 23, 2008
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Michael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, et al.
The New England Journal of Medicine
|
February 14, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer
Michael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group
Peter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
Breast Care (Basel, Switzerland)
|
June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
Page
of 9